Literature DB >> 9880994

A study of interval censoring in parametric regression models.

J K Lindsey1.   

Abstract

Parametric models for interval censored data can now easily be fitted with minimal programming in certain standard statistical software packages. Regression equations can be introduced, both for the location and for the dispersion parameters. Finite mixture models can also be fitted, with a point mass on right (or left) censored observations, to allow for individuals who cannot have the event (or already have it). This mixing probability can also be allowed to follow a regression equation. Here, models based on nine different distributions are compared for three examples of heavily censored data as well as a set of simulated data. We find that, for parametric models, interval censoring can often be ignored and that the density, at centres of intervals, can be used instead in the likelihood function, although the approximation is not always reliable. In the context of heavily interval censored data, the conclusions from parametric models are remarkably robust with changing distributional assumptions and generally more informative than the corresponding non-parametric models.

Mesh:

Substances:

Year:  1998        PMID: 9880994     DOI: 10.1023/a:1009681919084

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  18 in total

1.  Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

Authors:  P M Odell; K M Anderson; R B D'Agostino
Journal:  Biometrics       Date:  1992-09       Impact factor: 2.571

2.  Interval censored survival data: a generalized linear modelling approach.

Authors:  C P Farrington
Journal:  Stat Med       Date:  1996-02-15       Impact factor: 2.373

Review 3.  Tutorial in biostatistics methods for interval-censored data.

Authors:  J C Lindsey; L M Ryan
Journal:  Stat Med       Date:  1998-01-30       Impact factor: 2.373

4.  Regression analysis of interval-censored survival data with covariates using log-linear models.

Authors:  D K Kim
Journal:  Biometrics       Date:  1997-12       Impact factor: 2.571

5.  Regression models for interval censored survival data: application to HIV infection in Danish homosexual men.

Authors:  B Carstensen
Journal:  Stat Med       Date:  1996-10-30       Impact factor: 2.373

6.  Analysis of doubly-censored survival data, with application to AIDS.

Authors:  V De Gruttola; S W Lagakos
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

7.  Remission duration: an example of interval-censored observations.

Authors:  G Rücker; D Messerer
Journal:  Stat Med       Date:  1988-11       Impact factor: 2.373

8.  Distribution-free regression analysis of grouped survival data.

Authors:  D A Pierce; W H Stewart; K J Kopecky
Journal:  Biometrics       Date:  1979-12       Impact factor: 2.571

9.  A semiparametric model for regression analysis of interval-censored failure time data.

Authors:  D M Finkelstein; R A Wolfe
Journal:  Biometrics       Date:  1985-12       Impact factor: 2.571

10.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

View more
  11 in total

1.  Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.

Authors:  Thuy C Vu; John G Nutt; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

2.  Predictive modelling for shelf life determination of nutricereal based fermented baby food.

Authors:  Prasad Rasane; Alok Jha; Nitya Sharma
Journal:  J Food Sci Technol       Date:  2014-09-10       Impact factor: 2.701

3.  A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening.

Authors:  Hormuzd A Katki; Li C Cheung; Barbara Fetterman; Philip E Castle; Rajeshwari Sundaram
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2015-03-17       Impact factor: 2.483

4.  Estimating the Distribution of the Incubation Periods of Human Avian Influenza A(H7N9) Virus Infections.

Authors:  Victor Virlogeux; Ming Li; Tim K Tsang; Luzhao Feng; Vicky J Fang; Hui Jiang; Peng Wu; Jiandong Zheng; Eric H Y Lau; Yu Cao; Ying Qin; Qiaohong Liao; Hongjie Yu; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-09-26       Impact factor: 4.897

5.  Joint modelling of longitudinal outcome and interval-censored competing risk dropout in a schizophrenia clinical trial.

Authors:  Ralitza Gueorguieva; Robert Rosenheck; Haiqun Lin
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2011-08-04       Impact factor: 2.483

6.  Regression modelling of interval censored data based on the adaptive ridge procedure.

Authors:  Olivier Bouaziz; Eva Lauridsen; Grégory Nuel
Journal:  J Appl Stat       Date:  2021-06-23       Impact factor: 1.416

7.  Pharmacodynamic Analysis of Morphine Time-to-Remedication Events in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Jeffery L Galinkin; Gregory B Hammer; Kristi L Glotzbach
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

8.  The Relationship Between the Human Immunodeficiency Virus-1 Transmission Network and the HIV Care Continuum in Los Angeles County.

Authors:  Adiba Hassan; Victor De Gruttola; Yunyin W Hu; Zhijuan Sheng; Kathleen Poortinga; Joel O Wertheim
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.

Authors:  William A Werbel; Sunjae Bae; Sile Yu; Fawaz Al Ammary; Dorry L Segev; Christine M Durand
Journal:  Am J Transplant       Date:  2020-08-13       Impact factor: 8.086

10.  Bayesian inference of the Weibull model based on interval-censored survival data.

Authors:  Chris Bambey Guure; Noor Akma Ibrahim; Mohd Bakri Adam
Journal:  Comput Math Methods Med       Date:  2013-01-10       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.